Anzeige
❌
Mehr »
Mittwoch, 21.10.2026 - Börsentäglich über 12.000 News
Gewinnsprung und Milliardenmarkt im Rücken - 40 Mio. USD Auftragsbestand durch Methan-Altlasten
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von FiercePharma

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
DoKindeva lands $226M defense contract to supply nerve agent antidote in US
DoPar Health recalls 22 lots of IV blood thinner, its 3rd US product pull in a month
DoWith new Omvoh analyses, Lilly argues 'higher bar' for IBD treatment is within reach
DoIsotope supplier NorthStar continues rise with partnership to tee up China radiopharmaceutical filings
DoGilead puts a timely spotlight on HIV prevention in Latino communities with 'Ahorita Mismo' campaign
DoCompass puts treatment-resistant depression on the map with first awareness day
14.10.Ultragenyx makes swift $413M return on FDA review vouchers after summer of gene therapy nods
14.10.Connected Evidence: From Insight to Impac
14.10.Building trust in AI-assisted SLR: A reinvention of systematic literature reviews
14.10.Galderma bulks up dermatology portfolio with $1.5B acquisition of Zo Skin Health
14.10.United lands 'clearcut win' as Liquidia agrees to $380M settlement in Tyvaso patent infringement saga
14.10.AbbVie marks calendar for 'Time For Treks' in National Parks Foundation, CLL Society partnership
14.10.FTC seeks sanctions against Martin Shkreli over alleged pharma ban violations
14.10.NantWorks' Soon-Shiong puts chips behind manufacturing disruptors in new rounds for Prolific Machines, Multiply Labs
14.10.Sanofi dodges EU fine over alleged disparagement of CSL flu vaccine
13.10.Beyond Competitive Intelligence: Predicting Commercial Success Earlier in Drug Development
13.10.J&J's new pharma chief expects Icotyde's psoriasis launch momentum to repeat across indications
13.10.Syndax shares fall 17% after calling it quits on Niktimvo fibrosis program
13.10.BARDA awards Kaléo $96M contract to deploy auto-injector for chemical threat preparedness
13.10.ARPA-H program manager talks 'first-shoring' philosophy behind $125M RNA manufacturing network challenge
13.10.UCB fashions 'Wear It Out' project with empowering t-shirts, community for inflammatory disease patients
13.10.Galderma sculpts new narrative around menopausal skin changes to fill awareness gap
12.10.Data Precision Is Healthcare Marketing's Growth Engine
12.10.Mirum on its way to 3rd rare liver indication for Livmarli
12.10.Why Timing Has Become HCP Marketing's Biggest Challenge